Bristol Myers Squibb (BMY) Goodwill & Intangibles (2009 - 2026)

Bristol Myers Squibb has disclosed Goodwill & Intangibles across 18 years of filings, most recently posting $40.0 billion for Q1 2026.

• In Q1 2026, Goodwill & Intangibles fell 9.59% year-over-year to $40.0 billion; the TTM figure through Mar 2026 stood at $40.0 billion (down 9.59% YoY), while the FY2025 annual figure was $40.9 billion, down 9.26% from the prior year.
• Goodwill & Intangibles declined to $40.0 billion in Q1 2026, from $40.9 billion in the prior quarter.
• Over the last five years, Goodwill & Intangibles for BMY reached as high as $60.6 billion in Q1 2022 and fell as low as $40.0 billion in Q1 2026.
• The 5-year median for Goodwill & Intangibles is $50.1 billion (2023), against an average of $50.0 billion.
• Annual changes were most pronounced in 2024 — Goodwill & Intangibles retreated 0.43% — and 2025, when it fell 18.85%.
• A 5-year view of Goodwill & Intangibles shows it stood at $57.0 billion in 2022, then retreated by 15.38% to $48.2 billion in 2023, then slipped by 6.66% to $45.0 billion in 2024, then slipped by 9.26% to $40.9 billion in 2025, then slipped by 2.14% to $40.0 billion in 2026.
• According to Business Quant data, Goodwill & Intangibles over the past three periods registered $40.0 billion, $40.9 billion, and $42.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.